Cyclosporin immunosuppression of sheep: pharmacokinetics and allograft survival.

[1]  J. Turner,et al.  Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy. , 1998, British Journal of Cancer.

[2]  J. Reynoldson,et al.  CYCLOSPORINE A IMMUNOSUPPRESSION IN SHEEP WITH RESPONSE ENHANCEMENT BY CONCOMITANT KETOCONAZOLE , 1996, Clinical and experimental pharmacology & physiology.

[3]  P. Macdonald,et al.  Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. , 1995, The New England journal of medicine.

[4]  L. Benet,et al.  The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine , 1995, Clinical pharmacology and therapeutics.

[5]  L. Pennington,et al.  Clinical and Medicoeconomic Impact of the Cyclosporine‐Diltiazem Interaction in Renal Transplant Recipients , 1994, Pharmacotherapy.

[6]  R. Howard,et al.  A PRELIMINARY REPORT OF DILTIAZEM AND KETOCONAZOLE: THEIR CYCLOSPORINE‐SPARING EFFECT AND IMPACT ON TRANSPLANT OUTCOME1 , 1994, Transplantation.

[7]  L. Filippich,et al.  Pharmacokinetics and Absolute Bioavailability of Cyclosporin Following Intravenous and Abomasal Administration to Sheep , 1993, The Journal of pharmacy and pharmacology.

[8]  J. Alexander,et al.  CYCLOSPORINE‐KETOCONAZOLE INTERACTION: LONG‐TERM FOLLOW‐UP AND PRELIMINARY RESULTS OF A RANDOMIZED TRIAL , 1993, Transplantation.

[9]  K. Ilett,et al.  Comparison of cyclosporine measurement in whole blood by high-performance liquid chromatography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme-multiplied immunoassay. , 1992, Therapeutic drug monitoring.

[10]  B. Fellström,et al.  Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients. , 1992, Transplantation proceedings.

[11]  P. Maurel,et al.  Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  H. Valantine,et al.  Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  J. Borel.  Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo. , 1990, Pharmacological reviews.

[14]  C. Bonfils,et al.  Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[15]  P. Maurel,et al.  Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[16]  J. Derancourt,et al.  Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. , 1989, Drug metabolism and disposition: the biological fate of chemicals.

[17]  C. Burri,et al.  Factors affecting plasma levels of ketoconazole during long-term treatment. , 1989, Dermatologica.

[18]  J. Whitworth,et al.  THE HAEMODYNAMIC EFFECTS OF CYCLOSPORIN A IN SHEEP , 1987, Clinical and experimental pharmacology & physiology.

[19]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[20]  W Bablok,et al.  Comparison of Several Regression Procedures for Method Comparison Studies and Determination of Sample Sizes Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.